Sabra Health Care REIT Inc. (NASDAQ:SBRA) finished Wednesday with a subtraction of -$0.27 to close at $12.61, a downside of -2.10 percent. An average of 2,575,100 shares of common stock have been traded in the last five days. There was a fall of -$0.25 in the past week, and it reached a new high 4 times over the past 12 months. The last 20 days have seen an average of 2,204,845 shares traded, while the 50-day average volume stands at 2,331,174.
SBRA stock has increased by 2.19% in the last month. The company shares reached their 1-month lowest point of $11.75 on 07/10/23. With the stock rallying to its 52-week high on 02/02/23, shares of the company touched a low of $10.08 and a high of $16.41 in 52 weeks. It has reached a new high 11 times so far this year and achieved 1.45% or $0.18 in price. In spite of this, the price is down -23.16% from the 52-week high.
Valuation Metrics
Sabra Health Care REIT Inc. (SBRA) stock’s beta is 1.29. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 4.68, the price-to-book (PB) ratio at 0.98.
Financial Health
Further, the company has a long term debt to equity ratio of 0.81 and a total debt to equity ratio of 0.81 for the quarter ending June 29. Its gross profit as reported stood at $140.66 million compared to revenue of $624.81 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Sabra Health Care REIT Inc.’s return on assets was -2.20%.
Earnings Surprise
For the three-month period that ended June 29, Sabra Health Care REIT Inc. had $48.27 million in total debt. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of $21.19 million in the quarter, while revenues of -$9.49 million were grew 20.67%. The analyst consensus anticipated Sabra Health Care REIT Inc.’s latest quarter earnings to come in at $0.1 per share, but it turned out to be $0.09, a -10.00% surprise. For the quarter, EBITDA amounted to $102.47 million. At the end of the quarter ending June 29, Sabra Health Care REIT Inc.’s stock balance sheet showed total debt was $2.4 billion. Shareholders own equity worth $231.22 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Sabra Health Care REIT Inc. (SBRA) price momentum. RSI 9-day as of the close on 09 August was 39.77%, suggesting the stock is Neutral, with historical volatility in this time frame at 12.08%.
As of today, SBRA’s price is $12.79 -1.94% or -$0.25 from its 5-day moving average. SBRA is currently trading +1.45% higher than its 20-day SMA and +14.01% higher than its 100-day SMA. However, the stock’s current price level is +19.98% above the SMA50 and -0.71% below the SMA200.
The stochastic %K and %D were 30.78% and 36.33%, respectively, and the average true range (ATR) was 0.30. With the 14-day stochastic at 10.81% and the average true range at 0.28, the RSI (14) stands at 49.34%. The stock has reached -0.06 on the 9-day MACD Oscillator while the 14-day reading was at -0.15.
Analyst Ratings
Berenberg launched coverage on Sabra Health Care REIT Inc. (NASDAQ: SBRA) in its analyst report released on July 27, 2023. The firm assigned the stock a Hold rating. The consensus rating for Sabra Health Care REIT Inc. (SBRA) among analysts is Hold. According to current brokerage recommendations, 1 brokerage firm advise that investors sell SBRA, while 9 suggest investors hold. There are 1 analyst who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 4 others rate it as a “buy”.
What is SBRA’s price target for the next 12 months?
Analysts predict a range of price targets between $11.00 and $15.00, with a median target of $13.00. Taking a look at these predictions, the average price target given by analysts for Sabra Health Care REIT Inc. (SBRA) stock is $12.71.
